Alphatec (ATEC) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.03 per share. This compares to a loss of $0.28 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +200.00%. A quarter ago, it was expected that this medical equipment and supplies holding company would post a loss of $0.06 per share when it actually produced earnings of $0.02, delivering a surprise of +133.33% ...

Integra LifeSciences (IART) came out with quarterly earnings of $0.54 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.41 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +25.58%. A quarter ago, it was expected that this medical device maker would post earnings of $0.43 per share when it actually produced earnings of $0.45, delivering a surprise of +4.65%.Over the last four qua ...

TransMedics (TMDX) came out with quarterly earnings of $0.66 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.12 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +78.38%. A quarter ago, it was expected that this medical technology company would post earnings of $0.48 per share when it actually produced earnings of $0.92, delivering a surprise of +91.67%.Over the last four quart ...

AxoGen (AXGN) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.07 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +33.33%. A quarter ago, it was expected that this regenerative medicine company would post earnings of $0.06 per share when it actually produced earnings of $0.12, delivering a surprise of +100%.Over the last four quarters, ...

In the latest close session, Pacific Biosciences of California (PACB) was down 5.74% at $1.97. This change lagged the S&P 500's daily gain of 0.23%. Meanwhile, the Dow gained 0.34%, and the Nasdaq, a tech-heavy index, added 0.8%. The stock of maker of genetic analysis technology has risen by 67.2% in the past month, leading the Medical sector's gain of 5.57% and the S&P 500's gain of 3.57%.The investment community will be paying close attention to the earnings performance of Pacific Biosciences of Californi ...

Ekso Bionics (EKSO) came out with a quarterly loss of $0.54 per share versus the Zacks Consensus Estimate of a loss of $0.99. This compares to a loss of $1.5 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +45.45%. A quarter ago, it was expected that this robotic exoskeleton company would post a loss of $1.2 per share when it actually produced a loss of $1.24, delivering a surprise of -3.33%.Over the last four quarters, the co ...

OrthoPediatrics (KIDS) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.18 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +7.69%. A quarter ago, it was expected that this maker of orthopedic devices would post a loss of $0.17 per share when it actually produced a loss of $0.11, delivering a surprise of +35.29%.Over the last four quarters, t ...

The market expects PROCEPT BioRobotics Corporation (PRCT) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on November 4, might help the stock move higher if thes ...

IQVIA Holdings (IQV) came out with quarterly earnings of $3 per share, beating the Zacks Consensus Estimate of $2.96 per share. This compares to earnings of $2.84 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +1.35%. A quarter ago, it was expected that this clinical testing company would post earnings of $2.76 per share when it actually produced earnings of $2.81, delivering a surprise of +1.81%.Over the last four quarters, ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Hologic (HOLX) reports results for the quarter ended September 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on November 3, might help the stock move higher if these key numbers are better than expectati ...